Work

Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

Year: 2015

Type: article

Source: Journal of Clinical Immunology

DOI: 10.1007/s10875-015-0203-z

Authors: Seiji Yokoyama, Pin-Yu Perera, Seigo Terawaki, Nobumasa Watanabe, Osamu Kaminuma, Thomas A. Waldmann, Takachika Hiroi, Liyanage P. Perera

Institutions: Tokyo Metropolitan Institute of Medical Science, United States Department of Veterans Affairs, Veterans Health Administration, Washington DC VA Medical Center, National Cancer Institute, National Institutes of Health

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: IL-2:IL-15 : implications for cancer therapy

OpenAlex ID: W1860703945

FWCI: 0.984

Cites: 30

Cited by: 11

Related to: 10